Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Candida antigen is an effective and promising treatment for alopecia areata.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Liposomal adapalene improves delivery to hair follicles and reduces side effects for acne treatment.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

A new microneedle patch effectively and safely treats alopecia areata.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Dupilumab effectively treated severe alopecia areata in a child.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.